TeleCareSpot Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: LegitScript-certified GLP-1 care by mail, with published prices
TeleCareSpot scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed GLP-1s with published monthly pricing: semaglutide plans from $299/month and tirzepatide at $399/month at every dose, plus oral semaglutide, oral tirzepatide and phentermine. Its oral tirzepatide is compounded to your prescribed dose and paired with DNA results. Licensed US physicians review intake, with a decision typically in 3 to 5 days. It carries verifiable LegitScript certification, ships free, and is cancel-anytime. Available in 47 states and DC (not AK, MS, or NJ); the pharmacy is unnamed.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to TeleCareSpot
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
TeleCareSpot at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral semaglutide, Oral tirzepatide
- Starting price
- $299/mo (starting dose)
- What's included
- Medication · Consult · Shipping
- Availability
- 47 states + DC
- FDA status
- No FDA warning letter on record
How we scored TeleCareSpot
Each dimension is scored algorithmically from TeleCareSpot’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
5.7/10At $299/mo (starting dose), TeleCareSpot runs about 67% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.4/10TeleCareSpot offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.6/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
8.3/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.5/10TeleCareSpot is available in 47 states plus DC: all but Alaska, Mississippi, New Jersey.
Support10%
6.1/10TeleCareSpot provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this TeleCareSpot review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 47 states plus DC
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $299–$399/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with TeleCareSpot
We walked TeleCareSpot’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Register and answer questions about your medical history.
- 2A provider reviews your answers and prescribes if you are eligible.
- 3You receive ongoing care and support.
- 4Prescribed medication ships to your address.
- Plan prices are shown before intake: semaglutide from $299/month and tirzepatide at $399/month.
- Offers doctor-prescribed semaglutide, tirzepatide, oral semaglutide, oral tirzepatide, and phentermine, 100% online.
- You can cancel the subscription anytime with no long-term commitment.
- If not approved, you receive a full refund minus a consultation fee (fee is absorbed into medication packages if approved).
- Free shipping; service unavailable in Alaska, Mississippi, and New Jersey.
TeleCareSpot customer support
GLP-1 medications TeleCareSpot offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Plans start at $299/month; everything included, no hidden fees. Separate consult fee credited toward the package if approved.
$399/month at every prescribed dose; everything included. Oral semaglutide, oral tirzepatide and phentermine also offered (price at intake).
Ready to get started?
Plans and promotions change often, so check TeleCareSpot's current pricing and active discounts before you decide.
What we like
- Published monthly prices with no hidden fees: semaglutide plans from $299/month, tirzepatide $399/month at every dose
- Verifiable LegitScript certification (seal ID 45936855) plus HIPAA compliance and licensed US physicians
- Multiple options: semaglutide, tirzepatide, oral semaglutide, oral tirzepatide, and phentermine
- Oral tirzepatide is compounded to your prescribed dose and paired with your DNA results
- Broad coverage in 47 states and DC, with free shipping and cancel-anytime plans
- Fast online flow: physician decision typically within 3 to 5 days, then delivery
Watch-outs
- Injectable pages don't say whether medication is compounded, and the pharmacy isn't named; compounded drugs aren't FDA-approved
- Not available in Alaska, Mississippi, or New Jersey
- A separate weight-loss consultation fee applies (credited toward your medication package if approved)
- No refunds once medication leaves the pharmacy or the pharmacy has processed the order
- Trustpilot rating and review counts (4.9, 14,000+) are self-stated on the site
Is TeleCareSpot worth it?
TeleCareSpot's whole pitch comes down to this: LegitScript-certified GLP-1 care by mail, with published prices. It runs $299/month (starting dose); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its standout is a needle-free oral option for people who would rather not inject.
On top of the core program, it is LegitScript-certified.
How much TeleCareSpot costs
Compounded semaglutide runs $299/month (starting dose) and compounded tirzepatide runs $399/month (see plan details).
Because TeleCareSpot's headline figure is a starting dose, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare TeleCareSpot with the month-to-month prices of the alternatives below instead.
MangoRx (about $299/month) is one of the closest alternatives to weigh TeleCareSpot against.
Medications: what TeleCareSpot prescribes
TeleCareSpot prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
TeleCareSpot's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who TeleCareSpot is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
TeleCareSpot is available in 47 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
TeleCareSpot is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
TeleCareSpot scores highest on state availability and ease of access.
Ready to start with TeleCareSpot?
From $299/mo (starting dose). See current pricing and start your free consultation.
TeleCareSpot might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare TeleCareSpot vs…
TeleCareSpot scores7.4/10
Side-by-side pricing, medications and scores. Pick a matchup.
TeleCareSpot vs Amazon One Medical
Amazon One Medical scores 8.5/10
TeleCareSpot vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this TeleCareSpot review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See TeleCareSpot's current pricing
Plans from $299/mo (starting dose). Start your free consultation to check eligibility and today's price.